Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00213_DB00758> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00213_DB00758 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00213_DB00758 label "DDI between Pantoprazole and Clopidogrel - Pantoprazole may decrease serum concentrations of the active metabolite(s) of clopidogrel. Due to the possible risk for impaired clopidogrel effectiveness with this combination, clinicians should carefully consider the need for concurrent pantoprazole therapy in patients receiving clopidogrel. Monitor response to clopidogrel closely when using clopidogrel with pantoprazole. Whether there are differences among individual proton pump inhibitors is unclear. Other acid-lowering therapies (e.g., H2-receptor antagonists, antacids, etc.) do not appear to share this interaction with clopidogrel. [drugbank_resource:DB00213_DB00758]" assertion.
- drugbank_resource:DB00213_DB00758 identifier "drugbank_resource:DB00213_DB00758" assertion.
- drugbank_resource:DB00213_DB00758 title "DDI between Pantoprazole and Clopidogrel - Pantoprazole may decrease serum concentrations of the active metabolite(s) of clopidogrel. Due to the possible risk for impaired clopidogrel effectiveness with this combination, clinicians should carefully consider the need for concurrent pantoprazole therapy in patients receiving clopidogrel. Monitor response to clopidogrel closely when using clopidogrel with pantoprazole. Whether there are differences among individual proton pump inhibitors is unclear. Other acid-lowering therapies (e.g., H2-receptor antagonists, antacids, etc.) do not appear to share this interaction with clopidogrel." assertion.